Article
CALU polymorphism A29809G affects calumenin availability involving vascular calcification.
Journal of molecular and cellular cardiology - 1 May 2015
Jover Eva, Marín Francisco, Quintana Míriam, Pérez-Andreu Joaquín, Hurtado José Antonio, Rodríguez Cristina, Martínez-González José, González-Conejero Rocío, Valdés Mariano, Hernández-Romero Diana
Abstract excerpt
Calumenin inhibits gamma-carboxylation of matrix-Gla-protein preventing BMP2-dependent calcification. Our aim was to explore the clinical relevance and functionality of the CALU polymorphism rs1043550, and the relationship of calumenin time-dependent expression profile with the active calcification of human vascular smooth muscle cells (hVSMC). Coronary artery calcium score and lesion severity were assessed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
